Entry of hepatitis B virus: Mechanism and new therapeutic target;Entrée du virus de l'hépatite B: mécanisme et nouvelle cible thérapeutique

Pathologie Biologie

Volumn 58, Issue 4, 2010, Pages 301-307

  Xie, Y ^a,b   Zhai, J ^a   Deng, Q ^c   Tiollais, P ^d   Wang, Y ^b   Zhao, M ^b  

^a FUDAN UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

^d INSTITUT PASTEUR   (France)

Author keywords

Entry; Hepatitis B virus; Peptide; PreS1; Primary hepatocyte

Indexed keywords

ANTIVIRUS AGENT; ASIALOGLYCOPROTEIN RECEPTOR; BETA2 GLYCOPROTEIN 1; CYSTEINE; FIBRONECTIN; GLYCINE; GLYCOPROTEIN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 6; LIPOCORTIN 5; LIPOPROTEIN LIPASE; MEMBRANE PROTEIN; SERUM ALBUMIN; TRANSFERRIN RECEPTOR; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CULTURE; DRUG TARGETING; EXPERIMENTAL MODEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL; NONHUMAN; PROTEIN DOMAIN; PROTEIN INTERACTION; SCANDENTIA; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MEMBRANE PROTEINS; TUPAIA; VIRAL PROTEINS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 77955414884     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2010.04.001     Document Type: Article

References (76)

1. Tiollais P., Charnay P., Vyas G.N. Biology of hepatitis B virus. Science 1981, 213:406-411.
2. Ganem D., Prince A.M., Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004, 350:1118-1129.
3. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006, 28:112-125.
4. Perrillo R. Benefits and risks of interferon therapy for hepatitis B. Hepatology 2009, 49:S103-111.
5. Zoulim F., Buti M., Lok A.S. Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?. J Viral Hepat 2007, 14(suppl. 1):29-36.
6. http://www.ictvonline.org/virusTaxonomy.asp?version=2009.
7. Seeger C., Mason W.S. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000, 64:51-68.
8. Pontisso P., Vidalino L., Quarta S., Gatta A. Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev 2008, 8:13-17.
9. Moolla N., Kew M., Arbuthnot P. Regulatory elements of hepatitis B virus transcription. J Viral Hepat 2002, 9:323-331.
10. Sells M.A., Chen M.L., Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 1987, 84:1005-1009.
11. Shih C.H., Li L.S., Roychoudhury S., Ho M.H. In vitro propagation of human hepatitis B virus in a rat hepatoma cell line. Proc Natl Acad Sci U S A 1989, 86:6323-6327.
12. Yang P.L., Althage A., Chung J., Chisari F.V. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A 2002, 99:13825-13830.
13. Glebe D., Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 2007, 13:22-38.
14. Ilan E., Burakova T., Dagan S., Nussbaum O., Lubin I., Eren R., et al. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology 1999, 29:553-562.
15. Brown J.J., Parashar B., Moshage H., Tanaka K.E., Engelhardt D., Rabbani E., et al. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice. Hepatology 2000, 31:173-181.
16. Gupta S., Bhargava K.K., Novikoff P.M. Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation. Semin Liver Dis 1999, 19:15-26.
17. Sandgren E.P., Palmiter R.D., Heckel J.L., Daugherty C.C., Brinster R.L., Degen J.L. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991, 66:245-256.
18. Petersen J., Dandri M., Gupta S., Rogler C.E. Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma. Proc Natl Acad Sci U S A 1998, 95:310-315.
19. Dandri M., Burda M.R., Gocht A., Török E., Pollok J.M., Rogler C.E., et al. Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation. Hepatology 2001, 34:824-833.
20. Dandri M., Burda M.R., Török E., Pollok J.M., Iwanska A., Sommer G., et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 2001, 33:981-988.
21. Dandri M., Burda M.R., Zuckerman D.M., Wursthorn K., Matschl U., Pollok J.M., et al. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with Tupaia hepatocytes. J Hepatol 2005, 42:54-60.
22. Walter E., Keist R., Niederöst B., Pult I., Blum H.E. Hepatitis B virus infection of Tupaia hepatocytes in vitro and in vivo. Hepatology 1996, 24:1-5.
23. Yan R.Q., Su J.J., Huang D.R., Gan Y.C., Yang C., Huang G.H. Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus. J Cancer Res Clin Oncol 1996, 122:283-288.
24. Yan R.Q., Su J.J., Huang D.R., Gan Y.C., Yang C., Huang G.H. Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1. J Cancer Res Clin Oncol 1996, 122:289-295.
25. Gripon P., Diot C., Theze N., Fourel I., Loreal O., Brechot C., et al. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol 1988, 62:4136-4143.
26. Gripon P., Diot C., Guguen-Guillouzo C. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 1993, 192:534-540.
27. Galle P.R., Hagelstein J., Kommerell B., Volkmann M., Schranz P., Zentgraf H. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology 1994, 106:664-673.
28. Mabit H., Vons C., Dubanchet S., Capel F., Franco D., Petit M.A. Primary cultured normal human hepatocytes for hepatitis B virus receptor studies. J Hepatol 1996, 24:403-412.
29. Runge D.M., Runge D., Dorko K., Pisarov L.A., Leckel K., Kostrubsky V.E., et al. Epidermal growth factor and hepatocyte growth factor receptor activity in serum-free cultures of human hepatocytes. J Hepatol 1999, 30:265-274.
30. Köck J., Nassal M., MacNelly S., Baumert T.F., Blum H.E., von Weizsäcker F. Efficient infection of primary Tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol 2001, 75:5084-5089.
31. Köck J., Glebe D. Hepatitis B virus infection of primary Tupaia hepatocytes. Models of viral hepatitis. Basel Karger 2005, 25:96-105.
32. Gripon P., Rumin S., Urban S., Le Seyec J., Glaise D., Cannie I., et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 2002, 99:15655-15660.
33. Lee W.M. Hepatitis B virus infection. N Engl J Med 1997, 337:1733-1745.
34. Chai N., Chang H.E., Nicolas E., Han Z., Jarnik M., Taylor J. Properties of subviral particles of hepatitis B virus. J Virol 2008, 82:7812-7817.
35. Heermann K.H., Goldmann U., Schwartz W., Seyffarth T., Baumgarten H., Gerlich W.H. Large surface proteins of hepatitis B virus containing the pre-sequence. J Virol 1984, 52:396-402.
36. Bruss V., Lu X., Thomssen R., Gerlich W.H. Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J 1994, 13:2273-2279.
37. Ostapchuk P., Hearing P., Ganem D. A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis. EMBO J 1994, 13:1048-1057.
38. Prange R., Streeck R.E. Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J 1995, 14:247-256.
39. Neurath A.R., Kent S.B., Strick N., Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1986, 46:429-436.
40. Petit M.A., Dubanchet S., Capel F., Voet P., Dauguet C., Hauser P. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47). Virology 1991, 180:483-491.
41. Glebe D., Urban S., Knoop E.V., Cag N., Krass P., Grun S., et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and Tupaia hepatocytes. Gastroenterology 2005, 129:234-245.
42. Le Seyec J., Chouteau P., Cannie I., Guguen-Guillouzo C., Gripon P. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J Virol 1999, 73:2052-2057.
43. Macrae D.R., Bruss V., Ganem D. Myristylation of a duck hepatitis B virus envelope protein is essential for infectivity but not for virus assembly. Virology 1991, 181:359-363.
44. Bruss V., Hagelstein J., Gerhardt E., Galle P.R. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology 1996, 218:396-399.
45. Gripon P., Le Seyec J., Rumin S., Guguen-Guillouzo C. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 1995, 213:292-299.
46. Gripon P., Cannie I., Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol 2005, 79:1613-1622.
47. Petersen J., Dandri M., Mier W., Lütgehetmann M., Volz T., von Weizsäcker F., et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 2008, 26:335-341.
48. Engelke M., Mills K., Seitz S., Simon P., Gripon P., Schnolzer M., et al. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology 2006, 43:750-760.
49. Leistner C.M., Gruen-Bernhard S., Glebe D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol 2008, 10:122-133.
50. Schulze A., Gripon P., Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 2007, 46:1759-1768.
51. Deng Q., Zhai J.W., Michel M.L., Zhang J., Kong Y.Y., Qin J., et al. Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site. J Virol 2007, 81:4244-4254.
52. Chi S.W., Kim D.H., Lee S.H., Chang I., Han K.H. Pre-structured motifs in the natively unstructured preS1 surface antigen of hepatitis B virus. Protein Sci 2007, 16:2108-2117.
53. Fernholz D., Galle P.R., Stemler M., Brunetto M., Bonino F., Will H. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 1993, 194:137-148.
54. Le Seyec J., Chouteau P., Cannie I., Guguen-Guillouzo C., Gripon P. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J Virol 1998, 72:5573-5578.
55. Abou-Jaoude G., Sureau C. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus. J Virol 2005, 79:10460-10466.
56. Abou-Jaoude G., Sureau C. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J Virol 2007, 81:13057-13066.
57. Salisse J., Sureau C. A function essential to viral entry underlies the hepatitis B virus "a" determinant. J Virol 2009, 83:9321-9328.
58. Le Duff Y., Blanchet M., Sureau C. The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent. J Virol 2009, 83:12443-12451.
59. Neurath A.R., Strick N., Sproul P. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J Exp Med 1992, 175:461-469.
60. De Falco S., Ruvoletto M.G., Verdoliva A., Ruvo M., Raucci A., Marino M., et al. Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J Biol Chem 2001, 276:36613-36623.
61. Dash S., Rao K.V., Panda S.K. Receptor for pre-S1(21-47) component of hepatitis B virus on the liver cell: role in virus cell interaction. J Med Virol 1992, 37:116-121.
62. Neurath A.R., Strick N. Antigenic mimicry of an immunoglobulin A epitope by a hepatitis B virus cell attachment site. Virology 1990, 178:631-634.
63. Pontisso P., Ruvoletto M.G., Tiribelli G., Gerlich W.H., Ruol A., Alberti A. The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J Gen Virol 1992, 73:2041-2045.
64. Treichel U., Meyer zum Buschenfelde K.H., Stockert R.J., Poralla T., Gerken G. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J Gen Virol 1994, 75:3021-3029.
65. Franco A., Paroli M., Testa U., Benvenuto R., Peschle C., Balsano F., et al. Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. J Exp Med 1992, 175:1195-1205.
66. Mehdi H., Kaplan M.J., Anlar F.Y., Yang X., Bayer R., Sutherland K., et al. Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 1994, 68:2415-2424.
67. Stefas I., Rucheton M., D'Angeac A.D., Morel-Baccard C., Seigneurin J.M., Zarski J.P., et al. Hepatitis B virus Dane particles bind to human plasma apolipoprotein H. Hepatology 2001, 33:207-217.
68. Dash S., Rao K.V., Joshi B., Nayak N.C., Panda S.K. Significance of natural polymerized albumin and its receptor in hepatitis B infection of hepatocytes. Hepatology 1991, 13:134-142.
69. Imai M., Yanase Y., Nojiri T., Miyakawa Y., Mayumi M. A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg. Gastroenterology 1979, 76:242-247.
70. Gong Z.J., De Meyer S., van Pelt J., Hertogs K., Depla E., Soumillion A., et al. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection. Hepatology 1999, 29:576-584.
71. Budkowska A., Bedossa P., Groh F., Louise A., Pillot J. Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain. J Virol 1995, 69:840-848.
72. Budkowska A., Quan C., Groh F., Bedossa P., Dubreuil P., Bouvet J.P., et al. Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor. J Virol 1993, 67:4316-4322.
73. Ryu C.J., Cho D., Gripon P., Kim H.S., Guguen-Guillouzo C., Hong H.J. An 80-kilodalton protein that binds to the pre-S1 domain of hepatitis B virus. J Virol 2000, 74:110-116.
74. Tong S., Li J., Wands J.R. Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection. J Virol 1995, 69:7106-7112.
75. Tong S., Li J., Wands J.R. Carboxypeptidase D is an avian hepatitis B virus receptor. J Virol 1999, 73:8696-8702.
76. Breiner K.M., Urban S., Schaller H. Carboxypeptidase D (gp180), a Golgi-resident protein, functions in the attachment and entry of avian hepatitis B viruses. J Virol 1998, 72:8098-8104.